Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer.

Juan Luis Gomez MartiColin H BeckwittAmanda M ClarkAlan Wells

Published in: British journal of cancer (2021)

Atorvastatin could be used during adjuvant chemotherapy and also in conjunction with metastatic chemotherapy to reduce mTNBC cancer progression. These preclinical data establish a rationale for the development of randomised studies.

Keyphrases

squamous cell carcinoma
locally advanced
small cell lung cancer
clinical trial
papillary thyroid
open label
electronic health record
squamous cell
study protocol
double blind
rectal cancer
cell therapy
stem cells
randomized controlled trial
case control
machine learning